AGÕæÈ˹ٷ½

Stellus Capital Investment Corporation (NYSE: SCM) has filed a Form N-2 shelf registration that would allow the Business Development Company to issue up to $300 million of securities—including common and preferred stock, debt, warrants and subscription rights—on a delayed or continuous basis. The filing keeps the Company qualified under General Instruction A.2 and Rule 415, giving management flexibility to tap capital markets quickly as opportunities arise.

Capital structure & leverage. As of 31 March 2025, SCM had:

• Asset coverage ratio of 234 % (well above the 150 % minimum).
• Senior secured revolving Credit Facility commitment of $315 m (accordion to $350 m) with $221.8 m outstanding; maturity 2028; SOFR +2.50-2.75 % plus CSA.
• $100 m of 4.875 % unsecured notes due 2026.
• $75 m of newly issued 7.250 % unsecured notes due 2030.
• $308.8 m of SBA-guaranteed debentures across two SBIC subsidiaries.

The additional shelf capacity could push leverage higher, but management emphasises compliance with BDC asset-coverage limits and multiple covenants (liquidity � $10 m, interest coverage � 1.75×, etc.).

Potential dilution. The board already has shareholder authorisation (through June 2025) to issue common shares below NAV; the prospectus warns that such issuances would dilute existing holders and may pressure the market price. NAV was $13.25 at 31 Mar 2025 versus a market price of $13.81 on 12 Jun 2025 (4.2 % premium).

Investment strategy. SCM originates first-lien, unitranche, second-lien and unsecured loans to lower-middle-market private companies with $5-50 m EBITDA, often alongside equity co-investments. These loans are typically unrated and would likely be considered “junk� if rated. The adviser, Stellus Capital Management, may co-invest alongside affiliated funds under a 2022 SEC exemptive order.

Distribution profile. SCM pays monthly dividends of $0.1333 per share ($1.60 annualised), supports a dividend reinvestment plan (opt-out), and intends to maintain RIC status by distributing � 90 % of taxable income.

Use of proceeds. Net proceeds from any future offerings will be used for portfolio investments, debt repayment, and general corporate purposes; management targets deployment within three to six months while parking cash in short-term instruments pending investment.

Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., is offering $3.538 million of Autocallable Contingent Coupon Equity-Linked Securities linked to Target Corporation (TGT) stock, due July 6, 2027. The notes are unsecured senior obligations issued off the Series N MTN program and sold under prospectus supplement 424(b)(2).

Key economic terms:

• Stated principal: $1,000 per note; issue price 100%.
• Quarterly contingent coupon: 3.125 % (12.50 % p.a.) paid only if TGT’s closing price on the relevant valuation date is â‰� coupon barrier.
• Coupon & final barriers: $54.258 (55 % of the $98.65 initial underlying value).
• Autocall: On six scheduled dates from Dec 30 2025 to Mar 30 2027 the notes redeem at par plus coupon if TGT â‰� initial value.
• Maturity payment (if not called): Par if TGT â‰� final barrier; otherwise investors receive 10.13685 TGT shares (or cash equivalent), exposing them to full downside below the 55 % barrier and potentially total loss.
• Estimated value at pricing: $974.50 (2.55 % below issue price) reflecting structuring and hedging costs. Underwriting fee up to $18.50; net proceeds $981.50 per note.
• The securities will not be listed; liquidity is expected to be limited to CGMI’s discretionary secondary market.

Risk highlights (PS-6 to PS-9): investors may lose all principal if TGT falls >45 %; coupons are not guaranteed; early redemption can curtail income; exposure to Citi credit risk; product priced above estimated value; secondary market, if any, likely below issue price. U.S. federal tax treatment uncertain; withholding possible for non-U.S. holders.

Citi-specific impacts: The $3.5 million offering is immaterial to Citigroup’s capital base, but generates fee income and hedging flows. Because the product embeds short-put/long-bond economics, Citi hedges via equity derivatives, benefitting from bid/offer and funding spreads disclosed.

IGM Biosciences, Inc. (IGMS) � Form 4 filing dated 07/02/2025

Baker Bros. Advisors LP and affiliated investment funds (667, L.P. and Baker Brothers Life Sciences, L.P.) reported the receipt of 953 fully-vested restricted stock units (RSUs) on 06/30/2025. The RSUs were issued to Felix J. Baker in lieu of a $11,500 board retainer under the company’s Outside Director Compensation Policy. No cash was paid for the shares (price reported as $0).

Post-transaction indirect beneficial ownership stands at

• 357,048 common shares held for the benefit of 667, L.P.
• 3,763,362 common shares held for the benefit of Baker Brothers Life Sciences, L.P.

The filing is administrative in nature—reflecting routine director compensation rather than open-market buying or selling—and does not alter the group’s sizable strategic stake in the company.

LightWave Acquisition Corp. (Nasdaq: LWACU) filed an 8-K to report the successful completion of its initial public offering and related private placement. On 26 June 2025 the blank-check company issued 21,562,500 units at $10.00 each, including the full exercise of the underwriter’s 2,812,500-unit over-allotment option, producing $215.625 million of gross proceeds. Each unit contains one Class A ordinary share and one-half of a redeemable warrant exercisable at $11.50 per share.

Concurrently, the sponsor and BTIG, LLC purchased 606,250 private-placement units (390,625 and 215,625 units, respectively) at the same $10.00 price, generating an additional $6.062 million. No underwriting discount was paid on these units, which were issued under the Section 4(a)(2) exemption.

Total cash of $215.625 million—comprised of IPO net proceeds (after including $7.547 million of deferred underwriting discount) and private-placement proceeds—was deposited into a U.S. trust account at Continental Stock Transfer & Trust. The funds will be held until LightWave completes a business combination, consistent with standard SPAC practice.

An audited balance sheet dated 26 June 2025 reflecting these transactions is attached as Exhibit 99.1. No other material events were disclosed.

Form 4 filing for WESCO International Inc. (WCC) reports that Executive Vice President of Supply Chain & Operations, Hemant Porwal, acquired 5.8071 shares of common stock on 06/30/2025. The acquisition results from dividend equivalent rights (DERs) accruing on existing restricted stock units (RSUs); no cash was exchanged (price reported as $0). After the transaction, Porwal beneficially owns 20,529.7168 shares, held directly.

The DERs vest on the same schedule as the underlying RSU award and are economically equivalent to common shares. No derivative securities were bought or sold, and there were no dispositions. Given the very small share amount and routine nature of DER accruals, the filing is administrative and unlikely to materially affect WCC’s valuation or trading dynamics.

Post Holdings, Inc. (POST) â€� Form 4 filing dated 07/02/2025

Director William P. Stiritz reported an automatic acquisition of 101.906 Post Holdings stock equivalents on 06/30/2025 under the company’s Deferred Compensation Plan for Non-Management Directors. The units were credited at a reference price of $109.03 per share and bring Stiritz’s total holdings to 180,157.157 stock equivalents. These units are settled in cash, one-for-one with Post common stock value, when the director leaves the Board and carry no fixed exercise or expiration dates.

The filing indicates that Stiritz remains a non-management director and the transaction was coded “A,� reflecting an acquisition rather than a sale. No common shares were sold, and there were no changes to direct or indirect ownership structure beyond the additional units credited.

Post Holdings, Inc. (POST) â€� Form 4 filing dated 07/02/2025

Director William P. Stiritz reported an automatic acquisition of 101.906 Post Holdings stock equivalents on 06/30/2025 under the company’s Deferred Compensation Plan for Non-Management Directors. The units were credited at a reference price of $109.03 per share and bring Stiritz’s total holdings to 180,157.157 stock equivalents. These units are settled in cash, one-for-one with Post common stock value, when the director leaves the Board and carry no fixed exercise or expiration dates.

The filing indicates that Stiritz remains a non-management director and the transaction was coded “A,� reflecting an acquisition rather than a sale. No common shares were sold, and there were no changes to direct or indirect ownership structure beyond the additional units credited.

AG Mortgage Investment Trust, Inc. (MITT) â€� Form 4 Insider Transaction

Director Debra Ann Hess reported receiving 3,613 shares of common stock on 07/01/2025 under the company’s independent-director compensation policy. The shares are fully vested but may not be sold or transferred while she serves on the board. After this grant, Hess now beneficially owns 79,476 MITT shares, held directly. The transaction price is recorded as $0, reflecting a non-cash equity award rather than an open-market purchase.

AG Mortgage Investment Trust, Inc. (MITT) â€� Form 4 Insider Transaction

Director Debra Ann Hess reported receiving 3,613 shares of common stock on 07/01/2025 under the company’s independent-director compensation policy. The shares are fully vested but may not be sold or transferred while she serves on the board. After this grant, Hess now beneficially owns 79,476 MITT shares, held directly. The transaction price is recorded as $0, reflecting a non-cash equity award rather than an open-market purchase.